These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 14567610)

  • 1. Transcriptional expression of survivin and its splice variants in brain tumors in humans.
    Yamada Y; Kuroiwa T; Nakagawa T; Kajimoto Y; Dohi T; Azuma H; Tsuji M; Kami K; Miyatake S
    J Neurosurg; 2003 Oct; 99(4):738-45. PubMed ID: 14567610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation between transcriptional expression of survivin isoforms and clinicopathological findings in human colorectal carcinomas.
    Suga K; Yamamoto T; Yamada Y; Miyatake S; Nakagawa T; Tanigawa N
    Oncol Rep; 2005 May; 13(5):891-7. PubMed ID: 15809755
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The human survivin promoter: a novel transcriptional targeting strategy for treatment of glioma.
    Van Houdt WJ; Haviv YS; Lu B; Wang M; Rivera AA; Ulasov IV; Lamfers ML; Rein D; Lesniak MS; Siegal GP; Dirven CM; Curiel DT; Zhu ZB
    J Neurosurg; 2006 Apr; 104(4):583-92. PubMed ID: 16619663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transcriptional expression of survivin and its splice variants in cervical carcinomas.
    Futakuchi H; Ueda M; Kanda K; Fujino K; Yamaguchi H; Noda S
    Int J Gynecol Cancer; 2007; 17(5):1092-8. PubMed ID: 17877643
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative evaluation of survivin, midkine and CXCR4 promoters for transcriptional targeting of glioma gene therapy.
    Ulasov IV; Rivera AA; Sonabend AM; Rivera LB; Wang M; Zhu ZB; Lesniak MS
    Cancer Biol Ther; 2007 May; 6(5):679-85. PubMed ID: 17404502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expression of survivin and its splice variants, survivin-DeltaEx3 and survivin-2B, in bladder cancer.
    Atlasi Y; Mowla SJ; Ziaee SA
    Cancer Detect Prev; 2009; 32(4):308-13. PubMed ID: 19186007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of survivin splice isoforms in medulloblastomas.
    Li XN; Shu Q; Su JM; Adesina AM; Wong KK; Perlaky L; Antalffy BA; Blaney SM; Lau CC
    Neuropathol Appl Neurobiol; 2007 Feb; 33(1):67-76. PubMed ID: 17239009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional expression of survivin and its splice variants in endometriosis.
    Fujino K; Ueda M; Takehara M; Futakuchi H; Kanda K; Yamashita Y; Terai Y; Ueki M
    Mol Hum Reprod; 2006 Jun; 12(6):383-8. PubMed ID: 16644787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of different survivin variants in gastric carcinomas: first clues to a role of survivin-2B in tumour progression.
    Krieg A; Mahotka C; Krieg T; Grabsch H; Müller W; Takeno S; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Br J Cancer; 2002 Mar; 86(5):737-43. PubMed ID: 11875736
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional expression analysis of survivin splice variants reveals differential expression of survivin-3α in breast cancer.
    Moniri Javadhesari S; Gharechahi J; Hosseinpour Feizi MA; Montazeri V; Halimi M
    Genet Test Mol Biomarkers; 2013 Apr; 17(4):314-20. PubMed ID: 23368531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of survivin splice variants in pediatric acute precursor B lymphoblastic leukemia.
    Tröger A; Siepermann M; Mahotka C; Wethkamp N; Bülle H; Laws HJ; Escherich G; Janka-Schaub G; Göbel U; Dilloo D
    Klin Padiatr; 2007; 219(3):127-33. PubMed ID: 17525905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct expression of Survivin splice variants in breast carcinomas.
    Vegran F; Boidot R; Oudin C; Riedinger JM; Lizard-Nacol S
    Int J Oncol; 2005 Oct; 27(4):1151-7. PubMed ID: 16142334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct in vivo expression patterns of survivin splice variants in renal cell carcinomas.
    Mahotka C; Krieg T; Krieg A; Wenzel M; Suschek CV; Heydthausen M; Gabbert HE; Gerharz CD
    Int J Cancer; 2002 Jul; 100(1):30-6. PubMed ID: 12115583
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB activation and differential expression of survivin and Bcl-2 in human grade 2-4 astrocytomas.
    Angileri FF; Aguennouz M; Conti A; La Torre D; Cardali S; Crupi R; Tomasello C; Germanò A; Vita G; Tomasello F
    Cancer; 2008 May; 112(10):2258-66. PubMed ID: 18327814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expressions of survivin and the splice variants survivin-2B and survivin-DeltaEx3 in bladder cancer and their clinical significance].
    He XF; Wen DG; Hou JQ; He J; Cen JN
    Ai Zheng; 2009 Nov; 28(11):1209-13. PubMed ID: 19895744
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Are overexpressed alternative survivin transcripts in human bladder cancer suitable targets for siRNA-mediated in vitro inhibition?
    Wuttig D; Kunze D; Fuessel S; Toma M; Stade J; Kotzsch M; Kappler M; Taubert H; Schwenzer B; Baretton G; Hakenberg OW; Meye A; Wirth MP
    Int J Oncol; 2007 Jun; 30(6):1317-24. PubMed ID: 17487351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Do the survivin (BIRC5) splice variants modulate or add to the prognostic value of total survivin in breast cancer?
    Span PN; Tjan-Heijnen VC; Heuvel JJ; de Kok JB; Foekens JA; Sweep FC
    Clin Chem; 2006 Sep; 52(9):1693-700. PubMed ID: 16873289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of survivin-2B and survivin-DeltaEx3 is inversely associated with disease relapse and patient survival in non-small-cell lung cancer (NSCLC).
    Ling X; Yang J; Tan D; Ramnath N; Younis T; Bundy BN; Slocum HK; Yang L; Zhou M; Li F
    Lung Cancer; 2005 Sep; 49(3):353-61. PubMed ID: 15936846
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of survivin and its spliced variants in bladder tumors as a potential prognostic marker.
    Nouraee N; Mowla SJ; Ozhand A; Parvin M; Ziaee SA; Hatefi N
    Urol J; 2009; 6(2):101-8. PubMed ID: 19472128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and prognostic significance of survivin splice variants in diffusely infiltrating astrocytoma.
    Huang Y; Chen X; Chen N; Nie L; Xu M; Zhou Q
    J Clin Pathol; 2011 Nov; 64(11):953-9. PubMed ID: 21730264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.